VODNJAN, CROATIA--(BUSINESS WIRE)--NISSAN HAS REDEFINED CUSTOMER ENGAGEMENT BY PARTNERING WITH GLOBAL CLOUD COMMUNICATIONS PLATFORM INFOBIP TO PIONEER AN AGENTIC AI CAMPAIGN.
BEIJING, NOV. 05, 2025 (GLOBE NEWSWIRE) -- SUNLANDS TECHNOLOGY GROUP (NYSE: STG) ("SUNLANDS" OR THE "COMPANY"), A LEADER IN CHINA'S ADULT ONLINE EDUCATION MARKET AND CHINA'S ADULT PERSONAL INTEREST LEARNING MARKET, TODAY ANNOUNCED THAT IT WILL REPORT ITS THIRD QUARTER 2025 UNAUDITED FINANCIAL RESULTS ON THURSDAY, NOVEMBER 20, 2025, BEFORE THE OPEN OF U.S. MARKETS. SUNLANDS' MANAGEMENT TEAM WILL HOST A CONFERENCE CALL AT 7:00 A.M.
ZUG, SWITZERLAND, NOV. 05, 2025 (GLOBE NEWSWIRE) -- OCULIS HOLDING AG (NASDAQ: OCS / XICE: OCS) (“OCULIS”), A GLOBAL BIOPHARMACEUTICAL COMPANY FOCUSED ON BREAKTHROUGH INNOVATIONS TO ADDRESS SIGNIFICANT UNMET MEDICAL NEEDS IN NEURO-OPHTHALMOLOGY AND OPHTHALMOLOGY, ANNOUNCED TODAY THAT OCULIS' MANAGEMENT WILL PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER.
AUSTIN, TEXAS--(BUSINESS WIRE)--FAL.CON EUROPE, BARCELONA – CROWDSTRIKE (NASDAQ: CRWD) TODAY EXPANDED ITS AGENTIC SECURITY WORKFORCE, INTRODUCING NEW MISSION-READY AGENTS THAT EXTEND THE FALCON® PLATFORM AND DRIVE THE EVOLUTION OF THE AGENTIC SOC. BUILDING ON THE FIRST WAVE OF AGENTS INTRODUCED AT FAL.CON 2025, NEW AGENTS BRING AGENTIC AUTOMATION TO COMMON FALCON PLATFORM TASKS SUCH AS APP CREATION AND DATA ONBOARDING, ACCELERATING OUTCOMES AND LIBERATING ANALYSTS TO FOCUS ON THE STRATEGIC DECI.
AUSTIN, TEXAS--(BUSINESS WIRE)--FAL.CON EUROPE, BARCELONA – CROWDSTRIKE (NASDAQ: CRWD) TODAY ANNOUNCED CHARLOTTE AGENTIC SOAR, THE ORCHESTRATION LAYER OF THE FALCON AGENTIC SECURITY PLATFORM. CHARLOTTE AGENTIC SOAR ORCHESTRATES AI-POWERED AGENTS ACROSS THE SECURITY LIFECYCLE, CONNECTING CONTEXT AND DATA SO THEY CAN REASON AND ACT DYNAMICALLY TOGETHER IN REAL TIME UNDER ANALYST COMMAND. BY UNITING NATIVE, CUSTOM-BUILT, AND TRUSTED THIRD-PARTY AGENTS IN A SINGLE COORDINATED SYSTEM, CHARLOTTE AGEN.
CALGARY, ALBERTA--(BUSINESS WIRE)--E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), (“E3 LITHIUM” OR THE “COMPANY”) A LEADER IN CANADIAN LITHIUM DEVELOPMENT, REMINDS SHAREHOLDERS AND INTERESTED STAKEHOLDERS THE COMPANY IS HOSTING A WEBINAR THIS MORNING, NOVEMBER 5, 2025, AT 9:00AM MT. DURING THE PRESENTATION, CHRIS DOORNBOS, PRESIDENT AND CEO, AND MEMBERS OF THE E3 LITHIUM MANAGEMENT TEAM WILL DISCUSS: SUMMARY OF PHASE 1 DEMONSTRATION FACILITY ACHIEVEMENTS UPDATE ON PHASE 2 DEMONSTRATION.
POINT COMPLETES ITS SIXTH RATED SECURITIZATION, THE LARGEST BOND ISSUANCE IN THE HOME EQUITY INVESTMENT SPACE TO DATE, SIGNALING FURTHER MATURATION OF THE ASSET CLASS POINT COMPLETES ITS SIXTH RATED SECURITIZATION, THE LARGEST BOND ISSUANCE IN THE HOME EQUITY INVESTMENT SPACE TO DATE, SIGNALING FURTHER MATURATION OF THE ASSET CLASS
THE REPORT REVEALS 239 MALICIOUS PLAY APPS WITH OVER 42M USER INSTALLS THE REPORT REVEALS 239 MALICIOUS PLAY APPS WITH OVER 42M USER INSTALLS
HONG KONG, NOV. 05, 2025 (GLOBE NEWSWIRE) -- FUTU HOLDINGS LIMITED (“FUTU” OR THE “COMPANY”) (NASDAQ: FUTU), A LEADING TECH-DRIVEN ONLINE BROKERAGE AND WEALTH MANAGEMENT PLATFORM, TODAY ANNOUNCED THAT IT WILL REPORT ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, BEFORE U.S. MARKETS OPEN ON NOVEMBER 18, 2025.
MAJOR CUSTOMER RENEWAL, GLOBAL EXPANSION, AND NEW INNOVATIONS POSITION CORERO FOR CONTINUED GROWTH INTO 2026 LONDON , NOV. 5, 2025 /PRNEWSWIRE/ -- CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, TODAY REPORTED ACCELERATING GLOBAL GROWTH IN Q3 2025, FUELED BY RISING ORDER INTAKE AND CONTINUED INNOVATION ACROSS ITS SMARTWALL ONE™ PLATFORM, AND BEGAN Q4 WITH A MAJOR RENEWAL AND EXPANSION WITH A LEADING US CLOUD COMPUTING PROVIDER. BUILDING ON STRONG EXECUTION, CORERO ACHIEVED $7.4 MILLION IN Q3 ORDER INTAKE (UP FROM $6.0 MILLION IN Q3 2024) WITH NEW CUSTOMER WINS SPANNING THE US, UK, EUROPE, BRAZIL, AND SINGAPORE.
STOCKHOLM , NOV. 5, 2025 /PRNEWSWIRE/ -- MOBERG PHARMA AB (PUBL) HAS ENTERED INTO AN EXCLUSIVE LICENSING AGREEMENT WITH KARO HEALTHCARE AB REGARDING THE COMMERCIALIZATION OF MOB-015 (TERCLARA®) IN EUROPE. THE AGREEMENT COMPRISES 19 EUROPEAN MARKETS, ENABLING A COORDINATED LAUNCH ACROSS ALL KEY EU MARKETS UNDER THE LEADING GLOBAL ANTIFUNGAL BRAND LAMISIL®.
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 5, 2025) - KINGMAN MINERALS LTD. (TSXV: KGS) (OTCQB: KGSSF) (FSE: 47A) ("KINGMAN" OR THE "COMPANY") IS PLEASED TO UPDATE SHAREHOLDERS ON THE SIGNIFICANT PROGRESS TO DATE AT ITS FLAGSHIP MOHAVE PROJECT IN MOHAVE COUNTY, ARIZONA, WHICH INCLUDES THE HISTORIC ROSEBUD MINE.
SHANGHAI , NOV. 5, 2025 /PRNEWSWIRE/ -- CHINA PETROLEUM & CHEMICAL CORPORATION (HKG: 0386, "SINOPEC") HOSTED A THEMED FORUM AND A SIGNING CEREMONY ON NOVEMBER 4 AT THE 8TH CHINA INTERNATIONAL IMPORT EXPO (CIIE 2025). THE COMPANY SIGNED PURCHASING CONTRACTS WITH 34 PARTNERS FROM 17 COUNTRIES AND REGIONS, WHICH TOTALED US$40.9 BILLION, INCLUDING 24 PRODUCTS FROM 10 MAJOR CATEGORIES, INCLUDING CRUDE OIL, CHEMICALS, EQUIPMENT, MATERIALS, CONSUMER GOODS AND MORE.
PALO ALTO, CALIF.--(BUSINESS WIRE)--GUARDANT HEALTH, INC. (“GUARDANT HEALTH”) (NASDAQ: GH), A LEADING PRECISION ONCOLOGY COMPANY, TODAY ANNOUNCED THE PRICING OF AN UPSIZED UNDERWRITTEN PUBLIC OFFERING OF 3,333,333 SHARES OF GUARDANT HEALTH'S COMMON STOCK AT A PUBLIC OFFERING PRICE OF $90.00 PER SHARE (THE “COMMON STOCK OFFERING”). THE SIZE OF THE COMMON STOCK OFFERING WAS INCREASED FROM THE PREVIOUSLY ANNOUNCED $250.0 MILLION OF SHARES OF COMMON STOCK. IN ADDITION, GUARDANT HEALTH GRANTED THE U.
PALO ALTO, CALIF.--(BUSINESS WIRE)--GUARDANT HEALTH, INC. (“GUARDANT HEALTH”) (NASDAQ: GH), A LEADING PRECISION ONCOLOGY COMPANY, TODAY ANNOUNCED THE PRICING OF ITS UPSIZED OFFERING OF $350.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0% CONVERTIBLE SENIOR NOTES DUE 2033 (THE “NOTES”) IN A PRIVATE OFFERING (THE “CONVERTIBLE NOTES OFFERING”) TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS PURSUANT TO RULE 144A UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). TH.
NEW YORK , NOV. 5, 2025 /PRNEWSWIRE/ -- ONASSIS HOLDING CORP (OTC: ONSS) A US PUBLIC COMPANY PIONEERING CELLULAR REJUVENATION AND LONGEVITY BIOTECHNOLOGY, IS PLEASED TO ANNOUNCE THE APPOINTMENT OF ESQ. PAZ ITZHAKI-WEINBERGER TO ITS ADVISORY BOARD.
UXBRIDGE, ENGLAND / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / TRADING UPDATE FOR THE THIRD QUARTER ENDED 26 SEPTEMBER 2025 & INTERIM DIVIDEND DECLARATION SOLID THIRD QUARTER; REAFFIRMING FULL-YEAR GUIDANCE CHANGE VS 2024 REVENUE VOLUME (UC)[2] REVENUE PER UC[1],[2],[3] COMPARABLE VOLUME[1] REVENUE PER UC[1],[2],[3] FXN[1],[3] REVENUE REVENUE Q3 2025 EUROPE €4,194M 701M €6.01 0.9% 3.4% 4.2% 3.8% APS €1,216M 311M €4.23 (0.6)% 0.3% (0.2)% (7.7)% CCEP €5,410M 1,012M €5.46 0.4% 2.7% 3.2% 1.0% YTD 2025 EUROPE €11,665M 1,947M €5.99 0.1% 3.9% 3.0% 3.1% APS €4,019M 997M €4.23 11.5% (1.6)% 9.1% 3.9% CCEP €15,684M 2,944M €5.39 3.7% 1.7% 4.5% 3.3% CHANGE VS 2024 ADJUSTED COMPARABLE REVENUE[4] ADJUSTED COMPARABLE VOLUME (UC)[4] ADJUSTED COMPARABLE REVENUE PER UC[4] ADJUSTED COMPARABLE VOLUME[4] ADJUSTED COMPARABLE REVENUE PER UC[4] ADJUSTED COMPARABLE FXN REVENUE[4] ADJUSTED COMPARABLE REVENUE[4] Q3 2025 EUROPE €4,194M 701M €6.01 0.9% 3.4% 4.2% 3.8% APS €1,216M 311M €4.23 (0.6)% 0.3% (0.2)% (7.7)% CCEP €5,410M 1,012M €5.46 0.4% 2.7% 3.2% 1.0% YTD 2025 EUROPE €11,665M 1,947M €5.99 0.1% 3.9% 3.0% 3.1% APS €4,019M 997M €4.23 0.8% 2.3% 2.1% (2.8)% CCEP €15,684M 2,944M €5.39 0.3% 3.4% 2.7% 1.5% DAMIAN GAMMELL, CHIEF EXECUTIVE OFFICER, SAID: "2025 CONTINUES TO BE A SOLID YEAR FOR CCEP, REFLECTING OUR GREAT BRANDS, GREAT PEOPLE, GREAT EXECUTION AND STRONG RELATIONSHIPS WITH OUR BRAND PARTNERS AND CUSTOMERS. WE'VE DELIVERED ANOTHER QUARTER OF VOLUME GROWTH IN EUROPE, DESPITE SOFTER CONSUMER DEMAND.
CELLBXHEALTH PRESENTS PROOF-OF-CONCEPT STUDY USING ROCHE TISSUE DIAGNOSTICS' WORKFLOW AT WORLD-LEADING DRUG DEVELOPMENT CONFERENCE PARSORTIX PLATFORM SHOWN TO BE COMPATIBLE WITH THE ROCHE BENCHMARK ULTRA AUTOMATED STAINING SYSTEM, WITH INITIAL STUDY OF THREE KEY DRUG TARGETS: HER2 (BREAST), TROP2 (LUNG) AND PSMA (PROSTATE) GUILFORD, SURREY AND PLYMOUTH MEETING, PA / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / CELLBXHEALTH PLC (AIM:CLBX)(OTCQX:ANPCY), A GLOBAL LEADER IN CIRCULATING TUMOUR CELL (CTC) INTELLIGENCE, ANNOUNCES THE PRESENTATION OF A PROOF-OF-CONCEPT STUDY USING A ROCHE TISSUE DIAGNOSTICS WORKFLOW AT THE 16TH WORLD ADC CONFERENCE, SAN DIEGO, USA (NOV 3-6). THE WORLD ADC CONFERENCE IS THE LARGEST GLOBAL EVENT DEDICATED TO ANTIBODY-DRUG CONJUGATES (ADCS), ATTRACTING OVER 1,400 ATTENDEES FOCUSED ON ADVANCING TARGETED CANCER THERAPIES.
GROUP REVENUES OF € 535.1 M ((7.1)%); DISCOVERY & PRECLINICAL DEVELOPMENT SEGMENT ("D&PD", (12.3)%) STILL SEES SOFT DEMAND;JUST - EVOTEC BIOLOGICS ("JEB"; +11.3%) ABOVE-EXPECTATION; FURTHER ACCELERATING GROWTH ON NON-SANDOZ / NON-DOD BUSINESS STRONG SCIENTIFIC ADVANCEMENTS OF CO-DEVELOPED ASSET PIPELINE: EXPECTING UP TO FOUR MOLECULES IN CLINICAL PHASE II IN NEXT SIX TO NINE MONTHS SIGNING OF LANDMARK INDUSTRY TRANSACTION WITH SANDOZ ON 04 NOVEMBER, RESULTING IN PAYMENTS POTENTIALLY OVER US$ 650 M PLUS ROYALTIES ON PORTFOLIO OF UP TO 10 BIOSIMILAR MOLECULES 2025 GUIDANCE AND 2028 OUTLOOK CONFIRMED HAMBURG, DE / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, SDAX/TECDAX, PRIME STANDARD, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) TODAY ANNOUNCED ITS BUSINESS UPDATE FOR 9M 2025, ILLUSTRATING THE ONGOING SYSTEMATIC EXECUTION OF ITS STRATEGY. IN THE D&PD SEGMENT, THE MARKET FOR EARLY DRUG DISCOVERY SERVICES REMAINED SOFT, WHILE STRATEGIC PARTNERSHIPS ARE ON TRACK AND EVOTEC RECORDS STRONG PROGRESS IN ITS PARTNERED ASSET PIPELINE.
SANTA CLARA, CALIF.--(BUSINESS WIRE)---- $ACHR #ARCHER--TODAY ARCHER AVIATION INC. (NYSE: ACHR) ANNOUNCED THE JAPAN AIRLINES-LED CONSORTIUM, WHICH FEATURES ARCHER'S MIDNIGHT AIRCRAFT, WAS SELECTED BY THE TOKYO METROPOLITAN GOVERNMENT TO PARTICIPATE IN PHASE ONE OF TOKYO'S “EVTOL IMPLEMENTATION PROJECT.” PHASE ONE OF THE PROJECT WILL ASSESS THE MARKET AND BUILD THE OPERATING ECOSYSTEM, LEADING UP TO PLANNED DEMONSTRATION FLIGHTS OVER TOKYO BAY AND RIVER ROUTES, WHICH REPRESENTS CRITICAL STEPS TOWARDS RAMPING COMM.
LONDON, 5 NOVEMBER 2025- LIFT BIOSCIENCES, ('LIFT' OR 'THE COMPANY'), A RAPIDLY EMERGING BIOTECH AND THE GLOBAL LEADER IN NEUTROPHIL IMMUNOTHERAPIES, TODAY ANNOUNCES THAT PRECLINICAL DATA DEMONSTRATING THE POTENTIAL OF ITS FIRST-IN-CLASS IMMUNOMODULATORY ALPHA NEUTROPHILS (IMANS) TO RESTORE INNATE IMMUNE COMPETENCE AND REMODEL THE TUMOUR MICROENVIRONMENT (TME) IN SUPPORT OF ANTI-TUMOR IMMUNITY, WILL BE PRESENTED IN A POSTER AT THE 40TH SOCIETY FOR IMMUNOTHERAPY OF CANCER BEING HELD FROM 5-9 NOVEMBER IN NATIONAL HARBOR, MARYLAND.
WOLTERS KLUWER 2025 NINE-MONTH TRADING UPDATE ALPHEN AAN DEN RIJN, NOVEMBER 5, 2025 – WOLTERS KLUWER, A GLOBAL LEADER IN PROFESSIONAL INFORMATION SOLUTIONS, SOFTWARE AND SERVICES, TODAY RELEASES ITS SCHEDULED 2025 NINE-MONTH TRADING UPDATE. HIGHLIGHTS FULL-YEAR 2025 GUIDANCE REAFFIRMED.
AUSTIN, NOV. 05, 2025 (GLOBE NEWSWIRE) -- HORTICULTURE LIGHTING MARKET SIZE AND GROWTH INSIGHTS: ACCORDING TO THE SNS INSIDER,"THE HORTICULTURE LIGHTING MARKET SIZE WAS VALUED AT USD 4. 60 BILLION IN 2024 AND IS EXPECTED TO REACH USD 23. 08 BILLION BY 2032, GROWING AT A CAGR OF 22.
ST HELIER, JERSEY, NOV. 05, 2025 (GLOBE NEWSWIRE) -- (NYSE AMERICAN, AIM AND VFEX: CMCL) - CALEDONIA MINING CORPORATION PLC ("CALEDONIA" OR "THE COMPANY") IS PLEASED TO ANNOUNCE THE APPOINTMENT OF MR JULY NDLOVU TO THE BOARD OF DIRECTORS OF THE COMPANY (“THE BOARD”) AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR.
VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / GANDER GOLD CORPORATION ("GANDER" OR THE "COMPANY") (CSE:GAND)(OTCQB:GANDF), ANNOUNCES THAT THE BRITISH COLUMBIA SECURITIES COMMISSION ("BCSC") HAS ISSUED A FAILURE-TO-FILE CEASE TRADE ORDER ("FFCTO") DATED NOVEMBER 3, 2025, PURSUANT TO MULTILATERAL INSTRUMENT 11-103 - FAILURE-TO-FILE CEASE TRADE ORDERS IN MULTIPLE JURISDICTIONS . THE FFCTO WAS ISSUED AS A RESULT OF THE COMPANY'S FAILURE TO FILE THE FOLLOWING PERIODIC DISCLOSURE DOCUMENTS FOR THE FINANCIAL YEAR ENDED JUNE 30, 2025: ANNUAL AUDITED FINANCIAL STATEMENTS; ANNUAL MANAGEMENT'S DISCUSSION AND ANALYSIS ("MD&A"); AND CERTIFICATION OF ANNUAL FILINGS.
VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / SASSY GOLD CORP. (CSE:SASY)(OTCQB:SSYRF)(FSE:4E7) ("SASSY" OR "THE COMPANY") ANNOUNCES THAT THE BRITISH COLUMBIA SECURITIES COMMISSION ("BCSC") HAS ISSUED A FAILURE-TO-FILE CEASE TRADE ORDER ("FFCTO") DATED NOVEMBER 3, 2025, PURSUANT TO MULTILATERAL INSTRUMENT 11-103 - FAILURE-TO-FILE CEASE TRADE ORDERS IN MULTIPLE JURISDICTIONS. THE FFCTO WAS ISSUED AS A RESULT OF THE COMPANY'S FAILURE TO FILE THE FOLLOWING PERIODIC DISCLOSURE DOCUMENTS FOR THE FINANCIAL YEAR ENDED JUNE 30, 2025: ANNUAL AUDITED FINANCIAL STATEMENTS; ANNUAL MANAGEMENT'S DISCUSSION AND ANALYSIS ("MD&A"); AND CERTIFICATION OF ANNUAL FILINGS.
BAGSVÆRD, 5 NOVEMBER, 2025 - FINANCIAL REPORT FOR THE PERIOD 1 JANUARY 2025 TO 30 SEPTEMBER 2025 OPERATING PROFIT INCREASED BY 5% IN DANISH KRONER AND 10% AT CONSTANT EXCHANGE RATES (CER) TO DKK 95.9 BILLION, IMPACTED BY ONE-OFF RESTRUCTURING COSTS OF AROUND DKK 9 BILLION RELATED TO THE COMPANY-WIDE TRANSFORMATION WITH THE AIM OF STREAMLINING NOVO NORDISK'S OPERATIONS TO REINVEST FOR GROWTH. HAD NOVO NORDISK NOT INCURRED SUCH RESTRUCTURING COSTS AMOUNTING TO AROUND DKK 9 BILLION, OPERATING PROFIT WOULD HAVE INCREASED BY 15% IN DANISH KRONER AND 21% AT CER.
HIGHLIGHTS PROPORTIONATE POWER GENERATION AMOUNTED TO 574 GWH FOR THE REPORTING PERIOD, WITH ADDITIONAL 30 GWH OF COMPENSATED VOLUMES FROM ANCILLARY SERVICES AND AVAILABILITY WARRANTIES, BRINGING THE TOTAL PROPORTIONATE POWER GENERATION, INCLUDING THESE VOLUMES, TO 604 GWH. THE COMPANY NOW EXPECTS FULL-YEAR 2025 PROPORTIONATE POWER GENERATION, INCLUDING COMPENSATED VOLUMES, TO BE BETWEEN 850 AND 900 GWH.
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH; NASDAQ: IPHA) (“INNATE” OR THE “COMPANY”) TODAY ANNOUNCED THAT THE COMPANY WILL HOLD A CONFERENCE CALL ON THURSDAY, NOVEMBER 13, 2025, AT 2 P.M. CET / 8 A.M. ET, TO GIVE AN UPDATE ON BUSINESS PROGRESS DURING THE THIRD QUARTER OF 2025. PARTICIPANTS DURING THE CALL WILL BE: JONATHAN DICKINSON, CHIEF EXECUTIVE OFFICER SONIA QUARATINO, EXECUTIVE VICE PRESIDENT, CHIEF MEDICAL OFFICER YANNIS MOREL, EXECUTIVE V.
THE NETHERLANDS, 5 NOVEMBER 2025 VOPAK REPORTS STRONG PERFORMANCE, DRIVEN BY A RESILIENT PORTFOLIO KEY HIGHLIGHTS IMPROVE NET PROFIT -INCLUDING EXCEPTIONAL ITEMS- INCREASED YTD Q3 2025 BY 30% TO EUR 407 MILLION AND EPS OF EUR 3.51 INCREASED BY 37% YEAR-ON-YEAR PROPORTIONAL EBITDA -EXCLUDING EXCEPTIONAL ITEMS1- YTD Q3 2025 OF EUR 902 MILLION AN INCREASE OF 1% YEAR-ON-YEAR, ABSORBING NEGATIVE CURRENCY IMPACT OF EUR 18 MILLION YEAR-TO-DATE PROPORTIONAL OPERATING FREE CASH FLOW PER SHARE YTD Q3 2025 INCREASED BY 4% YEAR-ON-YEAR TO EUR 5.56 PER SHARE REFLECTING STRONG CASH FLOW GENERATION AND BENEFITS OF THE SHARE BUYBACK PROGRAMS IN 2024 AND 2025 CONFIRMING FY 2025 OUTLOOK DRIVEN BY CONTINUED STRONG AND RESILIENT PORTFOLIO PERFORMANCE, OFFSETTING NEGATIVE CURRENCY TRANSLATION EFFECTS GROW INVESTING IN ADDITIONAL THROUGHPUT CAPACITY IN REEF LPG TERMINAL IN CANADA, ADDRESSING HIGH DEMAND FOR ADDITIONAL EXPORT CAPACITY BY INVESTING EUR 34 MILLION EXPANDING INDUSTRIAL CAPACITY IN CAOJING AND HAITENG TERMINALS IN CHINA, STRENGTHENING OUR LEADING INDUSTRIAL POSITION EXPANDING LNG REGASIFICATION CAPACITY AT SPEC TERMINAL IN COLOMBIA BY INVESTING EUR 25 MILLION AVTL ANNOUNCED INVESTMENT DECISION TO BUILD A GREENFIELD GAS TERMINAL (LPG) AT JPNA PORT IN MUMBAI, INDIA AND PROPOSED TO ACQUIRE 75% OF THE SHARES OF HINDUSTAN AEGIS LPG LTD 60% OF THE PROPORTIONAL EUR 2.6 BILLION ALLOCATED TO GROW IN GAS AND INDUSTRIAL TERMINALS COMMITTED SINCE JUNE 2022 ACCELERATE SIGNED A JOINT VENTURE AGREEMENT WITH OQ IN OMAN, TO DEVELOP AND OPERATE ENERGY STORAGE AND TERMINAL INFRASTRUCTURE IN THE STRATEGIC LOCATION OF DUQM Q3 2025 Q2 2025 Q3 2024 IN EUR MILLIONS YTD Q3 2025 YTD Q3 2024 IFRS MEASURES -INCLUDING EXCEPTIONAL ITEMS- 321.6 322.6 325.0 REVENUES 973.1 978.7 87.9 218.8 99.3 NET PROFIT / (LOSS) ATTRIBUTABLE TO HOLDERS OF ORDINARY SHARES 406.5 311.8 0.77 1.89 0.83 EARNINGS PER ORDINARY SHARE (IN EUR) 3.51 2.56 258.5 189.9 219.4 CASH FLOWS FROM OPERATING ACTIVITIES (GROSS) 754.3 737.3 - 141.9 -159.1 -111.0 CASH FLOWS FROM INVESTING ACTIVITIES (INCLUDING DERIVATIVES) - 438.5 -375.3 ALTERNATIVE PERFORMANCE MEASURES -EXCLUDING EXCEPTIONAL ITEMS- 1 467.3 493.7 479.1 PROPORTIONAL REVENUES 1,449.4 1,432.5 286.5 315.4 294.1 PROPORTIONAL GROUP OPERATING PROFIT / (LOSS) BEFORE DEPRECIATION AND AMORTIZATION (EBITDA) 901.8 893.5 226.8 254.8 233.3 GROUP OPERATING PROFIT / (LOSS) BEFORE DEPRECIATION AND AMORTIZATION (EBITDA) 717.8 720.4 89.0 117.1 97.5 NET PROFIT / (LOSS) ATTRIBUTABLE TO HOLDERS OF ORDINARY SHARES 303.9 324.1 0.78 1.01 0.83 EARNINGS PER ORDINARY SHARE (IN EUR) 2.63 2.67 BUSINESS KPIS 35.8 35.8 35.2 STORAGE CAPACITY END OF PERIOD (IN MILLION CBM) 35.8 35.2 20.4 20.4 20.3 PROPORTIONAL STORAGE CAPACITY END OF PERIOD (IN MILLION CBM) 20.4 20.3 91% 91% 92% SUBSIDIARY OCCUPANCY RATE 91% 92% 90% 91% 92% PROPORTIONAL OCCUPANCY RATE 91% 92% FINANCIAL KPIS 1 14.7% 17.0% 15.1% PROPORTIONAL OPERATING CASH RETURN 16.2% 16.2% 2,679.6 2,735.8 2,574.9 NET INTEREST-BEARING DEBT 2,679.6 2,574.9 2.49 2.54 2.28 TOTAL NET DEBT : EBITDA 2.49 2.28 1.68 1.93 1.70 PROPORTIONAL OPERATING FREE CASH FLOW PER SHARE (IN EUR) 5.56 5.33 2.56 2.65 2.60 PROPORTIONAL LEVERAGE 2.56 2.60 CEO MESSAGE WE CONTINUED TO EXECUTE OUR STRATEGY AND ARE REPORTING STRONG RESULTS YEAR-TO-DATE. DEMAND FOR OUR SERVICES REMAINED STRONG RESULTING IN AN INCREASED PROPORTIONAL EBITDA COMPARED TO THE SAME PERIOD LAST YEAR.
PRATTELN, SCHWEIZ, 5. NOVEMBER 2025 - SANTHERA PHARMACEUTICALS (SIX: SANN) GIBT DAS CLOSING DER LIZENZGEBÜHRENVEREINBARUNG ÜBER 13 MILLIONEN US-DOLLAR BEKANNT, DIE ERSTMALS IM SEPTEMBER 2025 ANGEKÜNDIGT WURDE UND DIE WELTWEITE MARKTEINFÜHRUNG VON AGAMREE (VAMOROLONE) UNTERSTÜTZEN SOLL. DIE VEREINBARUNG WURDE URSPRÜNGLICH IM SEPTEMBER 2025 MIT R-BRIDGE, EINER TOCHTERGESELLSCHAFT DER CBC GROUP, GESCHLOSSEN UND UMFASST 25% DER NETTO-LIZENZGEBÜHREN FÜR AGAMREE VON CATALYST PHARMACEUTICALS, INC.
PRATTELN, SWITZERLAND, NOVEMBER 5, 2025 - SANTHERA PHARMACEUTICALS (SIX: SANN) ANNOUNCES THE CLOSING OF A USD 13 MILLION ROYALTY MONETIZATION AGREEMENT, FIRST ANNOUNCED IN SEPTEMBER 2025, TO SUPPORT THE GLOBAL LAUNCHES OF AGAMREE (VAMOROLONE). THE AGREEMENT WAS INITIALLY SECURED IN SEPTEMBER 2025 WITH R-BRIDGE, AN AFFILIATE OF CBC GROUP, COVERING 25% OF NET ROYALTIES ON AGAMREE FROM CATALYST PHARMACEUTICALS, INC.
NEW YORK, NOV. 05, 2025 (GLOBE NEWSWIRE) -- FIVERR INTERNATIONAL LTD. (NYSE: FVRR), THE COMPANY THAT IS TRANSFORMING THE WAY THE WORLD CREATES AND WORKS TOGETHER, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025. ADDITIONAL OPERATING RESULTS AND MANAGEMENT COMMENTARY CAN BE FOUND IN THE COMPANY'S SHAREHOLDER LETTER, WHICH IS POSTED TO ITS INVESTOR RELATIONS WEBSITE AT INVESTORS.FIVERR.COM .
COPENHAGEN, NOV. 05, 2025 (GLOBE NEWSWIRE) -- UNDER THE NEW AGREEMENT, ISS WILL DELIVER A COMPREHENSIVE RANGE OF SERVICES ACROSS BRISBANE AIRPORT'S DOMESTIC AND INTERNATIONAL TERMINALS, INCLUDING PASSENGER AND BAGGAGE SCREENING, AIRSIDE AND LANDSIDE PATROLS, INSPECTIONS, CCTV MONITORING AND RESPONSE, AND PRECINCT SECURITY.
THE BOARD OF MOWI ASA HAS RESOLVED ON 4 NOVEMBER 2025 TO MAKE A QUARTERLY DISTRIBUTION TO SHAREHOLDERS OF NOK 1.50 PER SHARE. MOWI ASA'S SHARES LISTED ON THE OSLO STOCK EXCHANGE WILL BE TRADED INCLUDING DIVIDEND UP TO AND INCLUDING 13 NOVEMBER 2025.
LUXEMBOURG, LU / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / TERNIUM S.A. (NYSE:TX) ANNOUNCED TODAY THAT ITS SUBSIDIARY TERNIUM INVESTMENTS S.
DXC RECEIVES 16 AWARDS GLOBALLY FROM ISG'S ASSESSMENT OF AWS PARTNERS ASHBURN, VA. , NOV. 5, 2025 /PRNEWSWIRE/ - DXC TECHNOLOGY (NYSE: DXC), A LEADING FORTUNE 500 GLOBAL TECHNOLOGY SERVICES PROVIDER, HAS BEEN NAMED A LEADER BY ISG, A LEADING GLOBAL TECHNOLOGY RESEARCH AND ADVISORY FIRM, IN ITS ISG PROVIDER LENS® AWS ECOSYSTEM PARTNERS STUDY ACROSS THE US, APAC, GERMANY, AND THE UK.
NEW PSAS FOR SKILLS-FIRST HIRING CAMPAIGN HIGHLIGHT THE COMPETITIVE ADVANTAGE OF HIRING STARS - WORKERS SKILLED THROUGH ALTERNATIVE ROUTES NEW YORK , NOV. 5, 2025 /PRNEWSWIRE/ -- BUILDING ON THE MEASURABLE SUCCESS OF THE FIRST "TEAR THE PAPER CEILING" LAUNCH IN 2022, THE AD COUNCIL AND OPPORTUNITY@WORK TODAY UNVEILED NEW PUBLIC SERVICE ADVERTISEMENTS (PSAS), TITLED "STORY UNFOLD," ENCOURAGING EMPLOYERS TO EMBRACE SKILLS-FIRST HIRING PRACTICES AND ACCESS OVERLOOKED TALENT. RESEARCH FROM LINKEDIN SHOWS THAT HIRING MANAGERS WHO START WITH SKILLS ARE 60% MORE LIKELY TO FIND A SUCCESSFUL HIRE.
THE WOODLANDS, TEXAS--(BUSINESS WIRE)--AS NOTED IN THE PRESS RELEASE DATED OCTOBER 23, 2025, KODIAK GAS SERVICES, INC. (NYSE: KGS), (“KODIAK” OR THE “COMPANY”) WILL HOST A CONFERENCE CALL AND WEBCAST TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 5, 2025 AT 11:00 A.M. EASTERN TIME (10:00 A.M. CENTRAL TIME). THE CALL AND WEBCAST MAY BE ACCESSED BY DIALING 877-407-4012 AND ASKING FOR THE KODIAK GAS SERVICES CALL AT LEAST 10 MINUTES PRIOR TO THE START TIME, OR BY ACCESSING.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 8, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST WPP PLC (NYSE: WPP), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SHARES BETWEEN FEBRUARY 27, 2025 AND JULY 8, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI , LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 23, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST JAMES HARDIE INDUSTRIES PLC (“JAMES HARDIE” OR THE “COMPANY”) (NYSE: JHX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SHARES BETWEEN MAY 20, 2025, AND AUGUST 18, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 17, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST CYTOKINETICS, INCORPORATED (NASDAQGS: CYTK), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI , LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 8, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST MAREX GROUP PLC (“MAREX” OR THE “COMPANY”) (NASDAQGS: MRX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN MAY 16, 2024 AND AUGUST 5, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 2, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST MOLINA HEALTHCARE, INC. (“MOLINA” OR THE “COMPANY”) (NYSE: MOH), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 5, 2025 AND JULY 23, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA.
NEW YORK CITY AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS WITH SUBSTANTIAL LOSSES THAT THEY HAVE UNTIL DECEMBER 30, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST SYNOPSYS, INC. (“SYNOPSYS” OR THE “COMPANY”) (NASDAQGS: SNPS), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN DECEMBER 4, 2024 AND SEPTEMBER 9, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 18, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST KBR, INC. (NYSE: KBR), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN MAY 6, 2025 AND JUNE 19, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF TEXAS.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 14, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST FLUOR CORPORATION (NYSE: FLR), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS.
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 12, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST V.F.
CULVER CITY, CALIF.--(BUSINESS WIRE)--IMMUNITYBIO, INC. (NASDAQ: IBRX), A LEADING IMMUNOTHERAPY COMPANY, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FISCAL QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025. IN THE THIRD QUARTER OF 2025, IMMUNITYBIO REPORTED $31.8 MILLION OF PRODUCT REVENUE, REPRESENTING A 434% INCREASE FROM $6.0 MILLION IN THE THIRD QUARTER OF 2024. THIS GROWTH REFLECTS CONTINUED COMMERCIAL TRACTION OF ANKTIVA IN COMBINATION WITH BCG IN BCG-UNRESPONSIVE NMIBC WITH CIS WITH OR.
XIAMEN, CHINA , NOV. 4, 2025 /PRNEWSWIRE/ -- EPWK HOLDINGS LTD. (NASDAQ: EPWK) (THE "COMPANY"), A COMPANY THAT CONNECTS BUSINESSES WITH GREAT TALENTS THROUGH INNOVATIVE AND EFFICIENT CLOUD-SOURCING PLATFORMS, TODAY ANNOUNCED THAT THE COMPANY RECEIVED A LETTER (THE "NOTIFICATION LETTER") FROM THE LISTING QUALIFICATIONS STAFF (THE "STAFF") OF THE NASDAQ STOCK MARKET, LLC ("NASDAQ"), NOTIFYING THE COMPANY THAT, AS OF OCTOBER 23, 2025, THE COMPANY'S CLASS A ORDINARY SHARES HAD A CLOSING BID PRICE OF $0.10 OR LESS FOR TEN CONSECUTIVE TRADING DAYS, AND ACCORDINGLY, THE COMPANY IS SUBJECT TO THE PROVISIONS CONTEMPLATED UNDER LISTING RULE 5810(C)(3)(A)(III).
PRESS RELEASENOKIA EXTENDS SOFTBANK CORP. PARTNERSHIP WITH NETWORK MODERNIZATION DEAL IN JAPAN NOKIA SELECTED TO MODERNIZE AND EXPAND SOFTBANK'S 4G AND 5G NETWORKS IN JAPAN DEAL INCLUDES NOKIA'S LATEST AIRSCALE PORTFOLIO AND AI-POWERED MANTARAY SOLUTION 5 NOVEMBER 2025 ESPOO, FINLAND – NOKIA TODAY ANNOUNCED AN EXPANSION OF ITS PARTNERSHIP WITH SOFTBANK CORP. (SOFTBANK) THROUGH A NEW DEAL TO SUPPLY ADVANCED 4G AND 5G RADIO ACCESS EQUIPMENT IN JAPAN. THE AGREEMENT ENCOMPASSES THE MODERNIZATION OF EXISTING NETWORK INFRASTRUCTURE AND THE EXPANSION OF 5G STANDALONE COVERAGE USING NOKIA'S CUTTING-EDGE AIRSCALE PORTFOLIO.
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF ATYR PHARMA, INC. (NASDAQ: ATYR) BETWEEN JANUARY 16, 2025 AND SEPTEMBER 12, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 8, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED ATYR PHARMA COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF BAXTER INTERNATIONAL INC. (NYSE: BAX) BETWEEN FEBRUARY 23, 2022 AND JULY 30, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 15, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED BAXTER COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF CYTOKINETICS, INC. (NASDAQ: CYTK) BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 17, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED CYTOKINETICS COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
LONDON, UK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ALPHATON CAPITAL CORP ("ALPHATON CAPITAL" OR THE "COMPANY") ( NASDAQ: ATON) - ALPHATON CAPITAL, A LEADING INVESTMENT FIRM FOCUSED ON DISRUPTIVE TECHNOLOGIES, TODAY ANNOUNCED IT HAS ACQUIRED AN ADDITIONAL 300,000 TON COIN TO ADD TO ITS TON DIGITAL ASSET TREASURY.
PRESENTATION WILL HIGHLIGHT PRECLINICAL DATA SUPPORTING THE POTENTIAL OF WVE-007 (INHBE GALNAC-SIRNA) AS A UNIQUE APPROACH FOR THE TREATMENT OF OBESITY DESIGNED TO DRIVE FAT LOSS WHILE PRESERVING MUSCLE MASS WITH ONCE OR TWICE ANNUAL DOSING
MILPITAS, CALIF. , NOV. 4, 2025 /PRNEWSWIRE/ -- ZEPP HEALTH CORPORATION ("ZEPP" OR THE "COMPANY") (NYSE: ZEPP) TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025.
HOUSTON--(BUSINESS WIRE)--COREBRIDGE FINANCIAL, INC. (NYSE: CRBG) TODAY ANNOUNCED THAT THE PREVIOUSLY ANNOUNCED SECONDARY OFFERING BY AMERICAN INTERNATIONAL GROUP, INC. (NYSE: AIG) OF COMMON STOCK OF COREBRIDGE FINANCIAL HAS PRICED AT $31.10 PER SHARE. THE OFFERING IS EXPECTED TO CLOSE ON NOVEMBER 6, 2025, SUBJECT TO CUSTOMARY CLOSING CONDITIONS. AIG, AS THE SELLING STOCKHOLDER, HAS OFFERED 32.6 MILLION EXISTING SHARES OF COMMON STOCK (OUT OF APPROXIMATELY 520 MILLION TOTAL SHARES OF COMMON STO.
NEW YORK--(BUSINESS WIRE)--THE ESTÉE LAUDER COMPANIES INC. (NYSE: EL) TODAY ANNOUNCES THE PRICING OF THE PREVIOUSLY ANNOUNCED REGISTERED PUBLIC OFFERING (THE “OFFERING”) OF THE COMPANY'S CLASS A COMMON STOCK, PAR VALUE $.01 PER SHARE, BY TRUSTS AFFILIATED WITH DESCENDANTS OF LEONARD A. LAUDER (THE “SELLING STOCKHOLDERS”) AT A PRICE TO THE PUBLIC OF $90 PER SHARE. THE SELLING STOCKHOLDERS WILL RECEIVE ALL OF THE PROCEEDS FROM THE OFFERING. THE COMPANY IS NOT SELLING ANY SHARES OF CLASS A COMMON.
THE TRORILUZOLE CLINICAL DEVELOPMENT PROGRAM ENCOMPASSED THE FIRST INDUSTRY CLINICAL TRIALS TO GENERATE DATA SHOWING THERAPEUTIC POTENTIAL IN PATIENTS WITH SPINOCEREBELLAR ATAXIA (SCA), A RARE GENETIC, INHERITED, LIFE-THREATENING NEURODEGENERATIVE DISEASE WITH NO TREATMENT OPTIONS. COMPELLING DATA FROM TRORILUZOLE'S NEW DRUG APPLICATION (NDA) INCLUDED: A 3-YEAR REAL-WORLD EVIDENCE STUDY (STUDY 206-RWE) SHOWING SLOWING OF SCA DISEASE PROGRESSION BY 50-70% IN TRORILUZOLE-TREATED PATIENTS COMPARED TO MATCHED UNTREATED EXTERNAL CONTROLS; > 50% RISK REDUCTION IN AES OF FALLS IN TRORILUZOLE-TREATED SUBJECTS COMPARED TO PLACEBO FROM THE SAFETY ANALYSIS OF THE 1-YEAR, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY -206; AND MULTIPLE SUPPORTIVE ANALYSES SHOWING A DELAY IN BECOMING WHEELCHAIR BOUND OR LOSING THE ABILITY TO WALK, DECREASED GAIT IMPAIRMENT AS MEASURED BY F-SARA AND OBJECTIVE VIDEO-BASED KINEMATIC ANALYSIS, AND IMPROVEMENT IN OVERALL FUNCTIONING AS ASSESSED BY THE CLINICIAN GLOBAL IMPRESSION (CGI) SCALE.
DELRAY BEACH, FL, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ACCORDING TO MARKETSANDMARKETS, THE SMART CITY PLATFORMS MARKET WILL GROW FROM USD 24. 51 BILLION IN 2025 TO USD 39. 52 BILLION BY 2030 AT A COMPOUNDED ANNUAL GROWTH RATE (CAGR) OF 10.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THE LAW FIRM OF KIRBY MCINERNEY LLP IS INVESTIGATING POTENTIAL CLAIMS AGAINST ALVOTECH (“ALVOTECH” OR THE “COMPANY”) (NASDAQ:ALVO). THE INVESTIGATION CONCERNS WHETHER THE COMPANY MAY HAVE VIOLATED FEDERAL SECURITIES LAWS OR ENGAGED IN OTHER UNLAWFUL BUSINESS PRACTICES.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THE LAW FIRM OF KIRBY MCINERNEY LLP IS INVESTIGATING POTENTIAL CLAIMS AGAINST BEYOND MEAT, INC. (“BEYOND MEAT” OR THE “COMPANY”) (NASDAQ:BYND). THE INVESTIGATION CONCERNS WHETHER THE COMPANY MAY HAVE VIOLATED FEDERAL SECURITIES LAWS OR ENGAGED IN OTHER UNLAWFUL BUSINESS PRACTICES.
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 4, 2025) - BLUE STAR GOLD CORP. (TSXV: BAU) (OTCQB: BAUFF) (FSE: 5WP0) ("BLUE STAR" OR THE "COMPANY") ANNOUNCES THAT, FURTHER TO ITS NEWS RELEASE OF OCTOBER 30, 2025, IT HAS CLOSED THE FIRST TRANCHE OF ITS NON-BROKERED PRIVATE PLACEMENT RAISING PROCEEDS OF $1,250,000 THROUGH THE ISSUANCE OF 5,000,000 FLOW-THROUGH COMMON SHARES (EACH, A "FT SHARE") AT $0.25 PER FT SHARE (THE "PRIVATE PLACEMENT"). THE FT SHARES WILL QUALIFY AS FLOW-THROUGH SHARES FOR PURPOSES OF THE INCOME TAX ACT (CANADA).
BENSALEM, PA.--(BUSINESS WIRE)--LAW OFFICES OF HOWARD G. SMITH ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF INVESTORS WHO PURCHASED CARMAX, INC. (“CARMAX” OR THE “COMPANY”) (NYSE: KMX) SECURITIES BETWEEN JUNE 20, 2025 AND SEPTEMBER 24, 2025, INCLUSIVE (THE “CLASS PERIOD”). CARMAX INVESTORS HAVE UNTIL JANUARY 2, 2026 TO FILE A LEAD PLAINTIFF MOTION. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CARMAX, INC. (KMX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN.
KEY HIGHLIGHTS FOLLOWING THE ACQUISITION, SINGAPORE WILL REPRESENT 89% OF THE PORTFOLIO – REINFORCING GEOGRAPHIC FOCUS WHILE ENHANCING INCOME STABILITY AND PORTFOLIO RESILIENCE. PRIME LOCATION WITH EXCELLENT CONNECTIVITY TO SUPPORT LONG-TERM INCOME GROWTH.
-POSITIVE DATA FROM PHASE IB STUDY OF ASC30 ORAL TABLET DEMONSTRATED UP TO 6.5% PLACEBO-ADJUSTED MEAN BODY WEIGHT REDUCTION; SAFE AND WELL TOLERATED WITH ONLY MILD-TO-MODERATE GASTROINTESTINAL (GI) ADVERSE EVENTS (AES) ACROSS ALL MULTIPLE ASCENDING DOSE (MAD) COHORTS. -PHASE IB STUDY DATA OF ASC30 SUBCUTANEOUS (SQ) INJECTION SHOWED THAT OBSERVED HALF-LIFE REACHED 46 DAYS FOR THE TREATMENT FORMULATION (INJECTION A) AND 75 DAYS FOR THE MAINTENANCE FORMULATION (INJECTION B).
LONDON--(BUSINESS WIRE)-- #DISPLAY--DISPLAY GLASS REVENUE REACHED A RECORD HIGH OF JPY 270 BILLION IN THE THIRD QUARTER OF 2025, DRIVEN BY INCREASES IN BOTH PRICE AND DEMAND, ACCORDING TO NEW RESEARCH FROM OMDIA. THIS REVENUE REPRESENTS A 5% QUARTER-OVER-QUARTER (QOQ) INCREASE AND 14% YEAR-OVER-YEAR (YOY) INCREASE. DISPLAY GLASS IS STILL TRADED IN JAPANESE YEN. STRONG REVENUE PERFORMANCE IN 3Q25 REFLECTS A SIGNIFICANT STRATEGIC SHIFT IN THE INDUSTRY. AFTER A SEVERE RECESSION IN 2011, GLASS MAKERS ENDURED.
SAN FRANCISCO AND SUZHOU, CHINA , NOV. 4, 2025 /PRNEWSWIRE/ -- INNOVENT BIOLOGICS, INC. ("INNOVENT") (HKEX: 01801), A WORLD-CLASS BIOPHARMACEUTICAL COMPANY THAT DEVELOPS, MANUFACTURES, AND COMMERCIALIZES HIGH-QUALITY MEDICINES FOR THE TREATMENT OF ONCOLOGY, AUTOIMMUNE, CARDIOVASCULAR AND METABOLIC, OPHTHALMOLOGY AND OTHER MAJOR DISEASE AREAS, ANNOUNCED THAT PRE-CLINICAL STUDY RESULTS OF IBI3011 (IL-1RAP MONOCLONAL ANTIBODY) AND IBI3034 (TACI/BCMA CHIMERIC FUSION PROTEIN) WERE SHOWCASED AT AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) ANNUAL MEETING 2025. DETAILS ARE LISTED BELOW: TITLE: IBI3011, A HUMANIZED ANTI-IL1RAP MONOCLONAL ANTIBODY, INHIBITS IL1, IL33, IL36-DRIVEN INFLAMMATION PATHWAY, AND ATTENUATES INFLAMMATION IN PRECLINICAL INFLAMMATORY DISEASE MODEL (IBI3011) ABSTRACT NUMBER : 0082 PRESENTATION FORM: POSTER TIME: OCTOBER 26, 2025 10:30 AM – 12:30 PM (CT) PRESENTER: DR. HONGLING TIAN IBI3011 IS AN INNOVATIVE HUMANIZED MONOCLONAL ANTIBODY BLOCKING IL1Α, IL1Β, IL36 SIMULTANEOUSLY, BY TARGETING THE EXTRACELLULAR DOMAIN OF IL1RAP.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 4, 2025 / GRANDE PORTAGE RESOURCES LTD.
DENVER--(BUSINESS WIRE)--GOLD RESOURCE CORPORATION (NYSE AMERICAN: GORO) (THE “COMPANY”) IS PLEASED TO ANNOUNCE ITS THIRD QUARTER OPERATIONAL RESULTS FROM ITS DON DAVID GOLD MINE (“DDGM”) NEAR OAXACA, MEXICO. “I'M PLEASED TO REPORT THAT WE ARE BEGINNING TO SEE ENCOURAGING SIGNS OF A TURNAROUND AT THE DON DAVID GOLD MINE IN MEXICO,” SAID ALLEN PALMIERE, PRESIDENT AND CEO. “WE'VE STARTED RECEIVING SOME OF THE GENTLY USED EQUIPMENT THAT WE ORDERED, AND IT IS ALREADY OPERATIONAL WITHIN THE MINE. DE.
EAGLE, IDAHO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THE PENNANT GROUP, INC. (NASDAQ: PNTG), THE PARENT COMPANY OF THE PENNANT GROUP OF AFFILIATED HOME HEALTH, HOSPICE, HOME CARE AND SENIOR LIVING COMPANIES, ANNOUNCES TWO SIGNIFICANT ACQUISITIONS THAT STRENGTHEN ITS PRESENCES IN KEY MARKETS.
STUART, FLA. , NOV. 4, 2025 /PRNEWSWIRE/ -- HEALTH IN TECH (NASDAQ: HIT), AN INSURTECH PLATFORM COMPANY BACKED BY THIRD-PARTY AI TECHNOLOGY, TODAY ANNOUNCED AN EXPANSION OF ITS AGENDA FOR THE INDEPENDENT INSURTECH SUMMIT TO BE HELD DURING WORLD ECONOMIC FORUM WEEK 2026 IN DAVOS, SWITZERLAND.
ROAD TOWN, BRITISH VIRGIN ISLANDS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- AURA MINERALS INC. (NASDAQ: AUGO) (B3: AURA33) (“AURA” OR THE “COMPANY”) ANNOUNCES THAT IT HAS FILED ITS AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND EARNINGS RELEASE (TOGETHER, “FINANCIAL AND OPERATIONAL RESULTS”) FOR THE PERIOD ENDED SEPTEMBER 30, 2025. THE FULL VERSION OF THE FINANCIAL AND OPERATIONAL RESULTS CAN BE VIEWED ON THE COMPANY'S WEBSITE AT WWW.AURAMINERALS.COM, ON SEDAR+ AT WWW.SEDARPLUS.CA.
HAMILTON, BERMUDA , NOV. 4, 2025 /PRNEWSWIRE/ -- NABORS INDUSTRIES LTD. ("NABORS" OR THE "COMPANY") (NYSE: NBR) TODAY COMMENTED ON THE RECENT CREDIT RATINGS ACTIONS TAKEN BY ALL THREE OF THE MAJOR CREDIT RATING AGENCIES.
TAMPA, FLA.--(BUSINESS WIRE)--EXZEO GROUP, INC. (NYSE:XZO) TODAY ANNOUNCED THE PRICING OF ITS INITIAL PUBLIC OFFERING (“IPO”) OF 8,000,000 SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $21.00. ALL SHARES BEING OFFERED ARE BEING SOLD BY EXZEO. IN ADDITION, EXZEO HAS GRANTED THE UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL 1,200,000 COMMON SHARES AT THE IPO PRICE, LESS UNDERWRITING DISCOUNTS AND COMMISSIONS. THE SHARES ARE EXPECTED TO BEGIN TRADING ON THE NEW YORK STOCK.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- MESOBLAST LIMITED (NASDAQ:MESO; ASX:MSB), GLOBAL LEADER IN ALLOGENEIC CELLULAR MEDICINES FOR INFLAMMATORY DISEASES, TODAY ANNOUNCED THAT THE U.S. FOOD & DRUG ADMINISTRATION (FDA) HAS SCHEDULED A MEETING IN EARLY DECEMBER TO DISCUSS MESOBLAST'S DATA ON OPIOID REDUCTION AND CESSATION FROM ITS FIRST PHASE 3 STUDY (MSB-DR003) OF REXLEMESTROCEL-L IN PATIENTS WITH CHRONIC LOW BACK PAIN (CLBP).
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS WITH SUBSTANTIAL LOSSES THAT THEY HAVE UNTIL JANUARY 2, 2026 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST CARMAX, INC. (NYSE: KMX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN JUNE 20, 2025 AND SEPTEMBER 24, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION I.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF WESTERN ALLIANCE BANCORPORATION (NYSE: WAL) RESULTING FROM ALLEGATIONS THAT WESTERN ALLIANCE BANCORPORATION MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
HAMILTON, BERMUDA , NOV. 4, 2025 /PRNEWSWIRE/ -- NABORS INDUSTRIES LTD. (NYSE: NBR) ("NABORS") TODAY ANNOUNCED THAT NABORS INDUSTRIES, INC. ("NII") HAS PRICED $700 MILLION IN AGGREGATE PRINCIPAL AMOUNT OF SENIOR PRIORITY GUARANTEED NOTES DUE 2032 (THE "NOTES").
ROAD TOWN, BRITISH VIRGIN ISLANDS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- AURA MINERALS INC. (NASDAQ: AUGO) (B3: AURA33) (“AURA” OR THE “COMPANY”) ANNOUNCED TODAY THAT THE COMPANY'S BOARD OF DIRECTORS (THE “BOARD”) HAS DECLARED AND APPROVED THE PAYMENT OF A DIVIDEND (THE “DIVIDEND”) OF US$0.48 PER COMMON SHARE (APPROXIMATELY US$ 40.1 2 MILLION IN TOTAL). THIS PAYMENT IS ABOVE THE MINIMUM FORESEEN IN THE COMPANY'S DIVIDEND POLICY (THE “DIVIDEND POLICY”).
DELRAY BEACH, FL, NOV. 04, 2025 (GLOBE NEWSWIRE) -- AUTOMOTIVE HYPERVISOR MARKET IS PROJECTED TO GROW AT A CAGR OF 27. 0% FROM 2022 TO 2027, TO REACH USD 566 MILLION BY 2027 FROM USD 171 MILLION IN 2022, AS PER THE RECENT STUDY BY MARKETSANDMARKETS.
SÃO PAULO, NOV. 4, 2025 /PRNEWSWIRE/ --ITAÚ UNIBANCO HOLDING S.A. ANNOUNCES TO ITS SHAREHOLDERS AND TO THE MARKET THAT THE CONDENSED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2025 AND THE MANAGEMENT DISCUSSION AND ANALYSIS FOR THE 3RD QUARTER OF 2025 ARE AVAILABLE ON THE INVESTOR RELATIONS WEBSITE.
SAN FRANCISCO--(BUSINESS WIRE)--FORGE GLOBAL HOLDINGS, INC. (“FORGE”) (NYSE: FRGE), A LEADING PROVIDER OF MARKETPLACE INFRASTRUCTURE, DATA SERVICES, AND TECHNOLOGY AND INVESTMENT SOLUTIONS FOR THE PRIVATE MARKET, TODAY ANNOUNCED THAT IT WILL REPORT ITS THIRD QUARTER FISCAL 2025 FINANCIAL RESULTS ON NOVEMBER 14, 2025. ABOUT FORGE FORGE (NYSE: FRGE) IS A LEADING PROVIDER OF MARKETPLACE INFRASTRUCTURE, DATA SERVICES AND TECHNOLOGY AND INVESTMENT SOLUTIONS FOR THE PRIVATE MARKET. FORGE SECURITIES L.
BOSTON , NOV. 4, 2025 /PRNEWSWIRE/ -- WAYFAIR INC. (NYSE: W) (THE "COMPANY," "WE" OR "WAYFAIR") TODAY ANNOUNCED THE PRICING BY ITS SUBSIDIARY, WAYFAIR LLC (THE "ISSUER"), OF ITS PRIVATE OFFERING OF $700 MILLION IN AGGREGATE PRINCIPAL AMOUNT OF 6.75% SENIOR SECURED NOTES DUE 2032 (THE "NOTES"). THE NOTES WILL MATURE ON NOVEMBER 15, 2032, UNLESS EARLIER REPURCHASED OR REDEEMED IN ACCORDANCE WITH THEIR TERMS.
ANCHORAGE, ALASKA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- FIRST NATIONAL BANK ALASKA'S (OTCQX:FBAK) NET INCOME FOR THE THIRD QUARTER OF 2025 WAS $21.4 MILLION, OR $6.75 PER SHARE. THIS COMPARES TO A NET INCOME OF $18.0 MILLION, OR $5.68 PER SHARE, FOR THE SAME PERIOD IN 2024.
SAN FRANCISCO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- PROMINENT SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN IS INVESTIGATING STRIDE, INC. (NYSE: LRN), THE ONLINE EDUCATION PLATFORM, FOR POTENTIAL VIOLATIONS OF THE U.S. SECURITIES LAWS FOLLOWING A SERIES OF NEGATIVE MARKET EVENTS AND SERIOUS FRAUD ALLEGATIONS THAT HAVE SEEN THE COMPANY'S STOCK PRICE PLUMMET. THE FIRM URGES INVESTORS IN STRIDE WHO SUFFERED SIGNIFICANT LOSSES TO SUBMIT YOUR LOSSES NOW.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS SELLERS OF ORDINARY SHARES, INCLUDING THOSE THAT SOLD INTO THE MERGER OF SINA CORPORATION (NASDAQ: SINA) BETWEEN OCTOBER 13, 2020 AND MARCH 22, 2021, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 18, 2025 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION.
TORONTO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- IN ACCORDANCE WITH REGULATORY REQUIREMENTS, DUNDEE CORPORATION (TSX: DC.A) (“DUNDEE” OR THE “CORPORATION”) ANNOUNCES THAT IT HAS EXERCISED 4,259,259 WARRANTS OF MAGNA MINING INC. (THE “ISSUER”) AT AN EXERCISE PRICE OF $0.405 PER WARRANT. EACH WARRANT WAS EXERCISABLE FOR ONE COMMON SHARE OF THE ISSUER.
NEW YORK--(BUSINESS WIRE)---- $KMX #CLASSACTIONLAWSUIT--THE LAW FIRM OF KIRBY MCINERNEY LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT - JASON CAP V. CARMAX, INC. - HAS BEEN FILED ON BEHALF OF INVESTORS WHO ACQUIRED CARMAX, INC. (“CARMAX” OR THE “COMPANY”) (NYSE:KMX) SECURITIES DURING THE PERIOD OF JUNE 20, 2025 THROUGH SEPTEMBER 24, 2025, INCLUSIVE (“THE CLASS PERIOD”). IF YOU SUFFERED A LOSS ON YOUR CARMAX INVESTMENTS, YOU HAVE UNTIL JANUARY 2, 2026 TO REQUEST LEAD PLAINTIFF APPOINTMENT. FOR MORE INFORMATION: [CONTACT THE FIR.
OLDWICK, N.J.--(BUSINESS WIRE)--AM BEST HAS COMMENTED THAT THE CREDIT RATINGS (RATINGS) OF PALOMAR HOLDINGS, INC. (PALOMAR) (DELAWARE) [NASDAQ: PLMR], THE ULTIMATE PARENT AND INSURANCE HOLDING COMPANY OF PALOMAR SPECIALTY INSURANCE COMPANY (PSIC) (PORTLAND, OR), PALOMAR EXCESS AND SURPLUS INSURANCE COMPANY (PESIC) (PHOENIX, AZ), PALOMAR SPECIALTY REINSURANCE COMPANY BERMUDA LTD. (PALOMAR RE) (BERMUDA) AND FIRST INDEMNITY OF AMERICA INSURANCE COMPANY (FIA) (MORRIS PLAINS, NJ) REMAIN UNCHANGED FO.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING FIRST FOUNDATION INC. (NYSE: FFWM ) RELATED TO ITS SALE TO FIRSTSUN CAPITAL BANCORP. UNDER THE TERMS OF THE PROPOSED TRANSACTION, FIRST FOUNDATION SHAREHOLDERS WILL RECEIVE 0.16083 OF A SHARE OF FIRSTSUN COMMON STOCK FOR EACH FIRST FOUNDATION COMMON STOCK. IS IT A FAIR DEAL?
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- THE LAW FIRM OF KIRBY MCINERNEY LLP IS INVESTIGATING POTENTIAL CLAIMS AGAINST UNIQURE N.V. (“UNIQURE” OR THE “COMPANY”) (NASDAQ:QURE). THE INVESTIGATION CONCERNS WHETHER THE COMPANY AND/OR MEMBERS OF ITS SENIOR MANAGEMENT MAY HAVE VIOLATED FEDERAL SECURITIES LAWS OR ENGAGED IN OTHER UNLAWFUL BUSINESS PRACTICES.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING SM ENERGY COMPANY (NYSE: SM ) RELATED TO ITS MERGER WITH CIVITAS RESOURCES, INC. UPON COMPLETION OF THE PROPOSED TRANSACTION, SM ENERGY SHAREHOLDERS WILL OWN APPROXIMATELY 48% OF THE COMBINED COMPANY. IS IT A FAIR DEAL?
VANCOUVER, BRITISH COLUMBIA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ENTRÉE RESOURCES LTD. (TSX:ETG; OTCQB:ERLFF – THE “COMPANY” OR “ENTRÉE”) HAS TODAY FILED ITS INTERIM FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.
MINNEAPOLIS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLEARFIELD, INC. (NASDAQ: CLFD), THE LEADER IN COMMUNITY BROADBAND FIBER CONNECTIVITY, TODAY ANNOUNCED THAT IT WILL RELEASE RESULTS FOR THE FOURTH QUARTER OF FISCAL 2025, ENDED SEPTEMBER 30, 2025, ON TUESDAY, NOVEMBER 25, 2025, BEFORE THE MARKET OPEN. THE COMPANY WILL HOST A CONFERENCE CALL AT 8:30 A.M. EASTERN TIME (7:30 A.M. CENTRAL TIME) TO DISCUSS ITS FINANCIAL RESULTS WITH THE INVESTMENT COMMUNITY.
HIGHLIGHTS: PRODUCED FIRST GOLD AT BAYAN KHUNDII ON SEPTEMBER 14 AND EXPECT TO ACHIEVE NAMEPLATE PRODUCTION BY END OF 2025 ANNOUNCED UPDATED INDEPENDENT MINERAL RESOURCE ESTIMATE FOR ZUUN MOD MOLYBDENUM-COPPER PORPHYRY PROJECT ENTERED OPTION AGREEMENT TO ACQUIRE UP TO 80% OF THE TEREG UUL COPPER-GOLD PORPHYRY PROSPECT HALIFAX, NOVA SCOTIA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ERDENE RESOURCE DEVELOPMENT CORP. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) ("ERDENE" OR THE "COMPANY") IS PLEASED TO ANNOUNCE OPERATING AND FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025, AND TO PROVIDE AN UPDATE ON THE BAYAN KHUNDII GOLD MINE (“BK”), OPERATED BY ERDENE MONGOL LLC (“EM”), THE COMPANY'S JOINT VENTURE WITH MONGOLIAN MINING CORPORATION (“MMC”). THIS RELEASE SHOULD BE READ IN CONJUNCTION WITH THE COMPANY'S Q3 2025 FINANCIAL STATEMENTS AND MD&A, AVAILABLE ON THE COMPANY'S WEBSITE AND SEDAR+.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING COEUR MINING, INC. (NYSE: CDE ) RELATED TO ITS MERGER WITH NEW GOLD, INC. UPON COMPLETION OF THE PROPOSED TRANSACTION, COEUR SHAREHOLDERS WILL OWN APPROXIMATELY 62% OF THE COMBINED COMPANY. IS IT A FAIR DEAL?
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ASSOCIATES PC (THE “M&A CLASS ACTION FIRM”), HAS RECOVERED MILLIONS OF DOLLARS FOR SHAREHOLDERS AND IS RECOGNIZED AS A TOP 50 FIRM IN THE 2024 ISS SECURITIES CLASS ACTION SERVICES REPORT. THE FIRM IS HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY AND IS INVESTIGATING EVOKE PHARMA, INC. (NASDAQ: EVOK ) RELATED TO ITS SALE TO QOL MEDICAL, LLC. UNDER THE TERMS OF THE PROPOSED TRANSACTION, EVOKE SHAREHOLDERS WILL RECEIVE $11.00 PER SHARE IN CASH. IS IT A FAIR DEAL?